LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 03-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,262 | 19,804 | 18,684 | N/A | N/A |
| Marketable Securities | 13,098 | 3,847 | 42 | N/A | N/A |
| Other current assets | 372 | 213 | 241 | 0 | 0 |
| TOTAL | $20,732 | $23,864 | $18,967 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,398 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 600 | 586 | 565 | 0 | 0 |
| TOTAL | $4,998 | $586 | $565 | $N/A | $N/A |
| Total Assets | $23,082 | $26,375 | $21,521 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 670 | 738 | 942 | 0 | 0 |
| Accrued Expenses | 206 | 398 | 263 | N/A | N/A |
| TOTAL | $1,702 | $1,915 | $1,962 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $641 | $892 | $1,151 | $N/A | $N/A |
| Total Liabilities | $2,343 | $2,807 | $3,113 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 141 | 140 | 120 | N/A | N/A |
| Retained earnings | -41,696 | -38,777 | -35,649 | N/A | N/A |
| Other shareholders' equity | -332 | -442 | -528 | 0 | 0 |
| TOTAL | $20,739 | $23,568 | $18,408 | $N/A | $N/A |
| Total Liabilities And Equity | $23,082 | $26,375 | $21,521 | $0 | $0 |